Oncolytics Biotech, Inc. (ONCY)
1.04
+0.10
(+11.23%)
USD |
NASDAQ |
May 29, 16:00
1.07
+0.03
(+2.88%)
After-Hours: 20:00
Oncolytics Biotech Total Assets (Quarterly) : 8.161M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Replimune Group, Inc. | 333.59M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.179B |
| Anixa Biosciences, Inc. | 15.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.29M |
| Shareholders Equity (Quarterly) | -5.13M |
| Debt to Equity Ratio | -0.099 |
| Current Ratio | 1.381 |
| Net Debt Paydown Yield | 0.05% |